Zydelig (idelalisib)

pCPA File Number: 20875
Negotiation Status:
Negotiations were not pursued
Indication(s):
Follicular Lymphoma
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
pCODR 10075
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: